Search research articles
Contact Us
Filters
Showing results (111-120 of 165) with videos related to
Page
of 17
Sort By:
Journal of Neuro-Oncology
|
September 9, 2025
NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas
Nishanth S Sadagopan, Mateo Gomez, Shashwat Tripathi, et al.
Journal of Neurosurgery
|
September 17, 2022
Gene expression analysis during progression of malignant meningioma compared to benign meningioma
Andrea D Maier, Alessandra Meddis, Christian Mirian, et al.
Nature Genetics
|
May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Calixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Research Square
|
June 12, 2025
NOTCH3 Drives Fatty Acid Oxidation and Ferroptosis Resistance in Aggressive Meningiomas
Nishanth S Sadagopan, Mateo Gomez, Shashwat Tripathi, et al.
Acta Neuropathologica
|
October 9, 2025
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cells
Catharina Lotsch, Rolf Warta, Fang Liu, et al.
Neuro-Oncology Advances
|
June 6, 2022
Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data
Jordan R Hansford, Jie Huang, Raelene Endersby, et al.
Genome Biology
|
April 3, 2020
CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma
S John Liu, Martina Malatesta, Brian V Lien, et al.
Neuro-Oncology
|
January 17, 2019
Advances in multidisciplinary therapy for meningiomas
Priscilla K Brastianos, Evanthia Galanis, Nicholas Butowski, et al.
Cell Reports
|
February 6, 2020
Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in Ependymoma
S John Liu, Stephen T Magill, Harish N Vasudevan, et al.
Acta Neuropathologica
|
April 24, 2023
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Justin Z Wang, Vikas Patil, Jeff Liu, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 165) with videos related to
Sort By:
Page
of 17
Journal of Neuro-Oncology
|
September 9, 2025
NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas
Nishanth S Sadagopan, Mateo Gomez, Shashwat Tripathi, et al.
Journal of Neurosurgery
|
September 17, 2022
Gene expression analysis during progression of malignant meningioma compared to benign meningioma
Andrea D Maier, Alessandra Meddis, Christian Mirian, et al.
Nature Genetics
|
May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Calixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Research Square
|
June 12, 2025
NOTCH3 Drives Fatty Acid Oxidation and Ferroptosis Resistance in Aggressive Meningiomas
Nishanth S Sadagopan, Mateo Gomez, Shashwat Tripathi, et al.
Acta Neuropathologica
|
October 9, 2025
Tumor-associated macrophages in meningiomas: a novel biomarker for poor survival outperforming the benefits of T cells
Catharina Lotsch, Rolf Warta, Fang Liu, et al.
Neuro-Oncology Advances
|
June 6, 2022
Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data
Jordan R Hansford, Jie Huang, Raelene Endersby, et al.
Genome Biology
|
April 3, 2020
CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma
S John Liu, Martina Malatesta, Brian V Lien, et al.
Neuro-Oncology
|
January 17, 2019
Advances in multidisciplinary therapy for meningiomas
Priscilla K Brastianos, Evanthia Galanis, Nicholas Butowski, et al.
Cell Reports
|
February 6, 2020
Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in Ependymoma
S John Liu, Stephen T Magill, Harish N Vasudevan, et al.
Acta Neuropathologica
|
April 24, 2023
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Justin Z Wang, Vikas Patil, Jeff Liu, et al.
Page
of 17